Chris Brown

Chris Brown is currently the Executive Director of Cell Therapy at Autolus Therapeutics, a role they began in 2024. With a robust background in oncology and business development, Chris has previously held positions such as Regional Account Director at Iovance Biotherapeutics and Regional Business Director at Verastem Oncology. They have extensive experience in sales leadership, having served as a Regional Area Director at TESARO and as a Senior Oncology Specialist at both Medivation and Novartis Pharmaceuticals. Chris earned a Bachelor of Business Administration in Accounting and Finance from Middle Tennessee State University from 1990 to 1993.